title: Liver transplantation for familial amyloidotic polyneuropathy in Australia.
abstract: Familial amyloidotic polyneuropathy type 1 (FAP-1) is a type of systemic amyloidosis caused by mutant transthyretin (mTTR) that is mainly produced in the liver. Most patients have progressive peripheral and autonomic neuropathy. Ten patients with FAP underwent orthotopic liver transplantation (OLT) at the Queensland Liver Transplant Service (Princess Alexandra Hospital, Brisbane, Australia). Nine patients are still alive, and one patient died of cardiac failure 10 days after OLT. Some symptoms of FAP were alleviated in some of the patients. OLT seems to be a worthwhile treatment for FAP, because it halts the progression of symptoms and achieves improvement in some patients.
authors.affiliation: Queensland Liver Transplant Service, Princess Alexandra Hospital, Brisbane, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Nishino
authors.forename: N
authors.initials: N
authors.lastname: Tagaya
authors.forename: S V
authors.initials: SV
authors.lastname: Lynch
authors.forename: C
authors.initials: C
authors.lastname: Steadman
authors.forename: G A
authors.initials: GA
authors.lastname: Balderson
authors.forename: R W
authors.initials: RW
authors.lastname: Strong
mesh_terms: D000328:Adult; D017772:Amyloid Neuropathies / Q000235:genetics* / Q000401:mortality / Q000601:surgery*; D001315:Australia; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D016042:Transplantation, Heterotopic